Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Will Market Vyrex's Epitope Tagging Technology Line


CARLSBAD, Calif.-- Invitrogen, maker of research tools for gene cloning and expression, has been granted exclusive worldwide license to market a line of products incorporating Vyrex's reading frame independent epitope tagging technology. Invitrogen will market products for research and development containing Vyrex's Universal DNA, Universal Epitope, or antibodies that recognize the epitope.

Vyrex claimed that the Universal Epitope tagging system could allow biologists to accelerate functional genomics by eliminating the need for full-sequence characterization and reading frame determination. The technology employs a DNA sequence that encodes the same polypepes and gene products.

Invitrogen also announced that it has appointed Donald Grimm to its board of directors. Grimm has more than 23 years of experience in pharmaceutical management at Eli Lilly and Hybritech.

Grimm is founder of Strategic Design, a consulting group focused on strategic planning, and has recently served as the West Coast representative for Copenhagen Capacity, a Danish trade group focused on biotechnology and medical devices. Previously he was chief executive officer of both Telios Pharmaceuticals and Hybritech.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.